US Patent 9345661 Subcutaneous anti-HER2 antibody formulations and uses thereof
Patent 9345661 was granted and assigned to Genentech on May, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9345661 Subcutaneous anti-HER2 antibody formulations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.